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INTRODUCTION
The exchange proteins directly activated by cAMP (adenosine 3′,5′-monophosphate), Epac1 and Epac2, also known as the cAMP-activated guanine nucleotide exchange factors cAMP-GEFI and cAMP-GEFII, are mediators of cAMP-regulated cellular processes (1) . These proteins regulate neurotransmitter and hormone release (2) (3) (4) (5) (6) , cell adhesion and junction formation (7) (8) (9) (10) , cell proliferation (11) , gene transcription (12) , and intracellular Ca 2+ handling (13) . Epac1 and Epac2 are multidomain proteins with an N-terminal regulatory region and a C-terminal catalytic region with GEF activity toward the small Ras family guanosine triphosphatases (GTPases) Rap1 and Rap2 (1) . The regulatory region consists of a DEP (disheveled, Egl-10, pleckstrin) domain and one or two cyclic nucleotide binding (CNB) domains. The catalytic region contains a Ras exchange motif (REM), a Ras association (RA) domain, and a CDC25 homology domain (1) . In the absence of cAMP, the Epac proteins have a compact structure in which the regulatory region blocks the catalytic region, keeping the protein in an autoinhibited state. Binding of cAMP to the CNB domain releases the autoinhibition (14) (15) (16) . Whereas Epac1 has one CNB domain, Epac2 has two with low and high affinities for cAMP. The high-affinity domain binds micromolar cAMP, a considerably higher concentration range than that necessary to activate cAMPdependent protein kinase (PKA) (17, 18) . The function of the low-affinity CNB domain is unclear, but it may be required for appropriate subcellular targeting of Epac2 (19) .
The Epac targets Rap1 and Rap2 localize to various membrane compartments, including the Golgi network, the nuclear membrane, the vesicular membranes, and the plasma membrane (20) (21) (22) . Activation of a specific pool of these proteins might be achieved by subcellular targeting of their upstream GEFs. Epac1 and Epac2 have been found both at the plasma membrane and at various organelle membranes (12, (23) (24) (25) (26) (27) . The mechanisms regulating the subcellular distribution of Epac proteins are not well understood. It has been reported that increases in the cAMP concentration trigger Epac1 translocation to the plasma membrane in a process that requires cAMP binding as well as an intact DEP domain (27) , which mediates binding to phosphatidic acid (28) . In addition, the cAMP-induced plasma membrane translocation of Epac1 is increased by binding of the N terminus of Epac1 to activated ezrin-radixin-moesin (ERM) proteins (29) . Epac2 differs from Epac1 in that its RA domain can bind to Ras-GTP (guanosine 5′-triphosphate). Overexpression of Ras in H1299 lung carcinoma cells thus targets Epac2 to the plasma membrane (25) , and the membrane association of Epac2 is lost if the RA domain is deleted or mutated (25, 26) . Whether binding of cAMP is required for membrane targeting of Epac2 is a matter of debate. The conformational change induced by cAMP binding is not necessary for exposing the RA domain (16) , and although Epac2 has been suggested to target to membranes by cAMP-independent interaction with Ras-GTP (26) , others have failed to observe membrane association of Epac2 in the absence of cAMP (25) .
Whereas Epac1 is present in most cells, Epac2 is primarily present in neuronal tissue, adrenal glands (30) , and pancreatic b cells (31) . In b cells, glucose triggers oscillations of the sub-plasma membrane Ca 2+ and cAMP concentrations that synergize to generate pulsatile insulin secretion (32) . Epac2 mediates PKA-independent amplification of insulin secretion by cAMP during stimulation with glucose (33) and the incretin hormone glucagon-like peptide-1 (GLP-1) (3) . Using quantitative real-time imaging with confocal and total internal reflection fluorescence (TIRF) microscopy, we have investigated how the subcellular distribution of Epac2 is controlled by dynamic changes of the sub-plasma membrane concentrations of cAMP and Ca 2+ as well as of endogenous Ras activity. We found that Epac2 cyclically translocated to and from the plasma membrane in response to cAMP and Ca 2+ signals. The Ca
2+
-dependent translocation was mediated by increased Ras activity and required a concomitant increase in the cAMP concentration. The periodic spatial redistribution of Epac2 was translated into oscillations of Rap GTPase activity in the plasma membrane compartment.
RESULTS cAMP induces translocation of Epac2 to the plasma membrane
Confocal imaging of MIN6 b cells immunostained for Epac2 showed that an increase in cAMP concentration induced by the phosphodiesterase inhibitor IBMX (3-isobutyl-1-methylxanthine) caused increased localization of endogenous Epac2 at the plasma membrane (Fig. 1A) . To study the kinetics of this translocation, we transfected MIN6 b cells with Epac2 with an N-terminal GFP (green fluorescent protein) fusion (GFPEpac2). Under basal conditions, GFP-Epac2 distributed evenly in the cytoplasm, but an IBMX-induced increase in the cAMP concentration caused reduced cytoplasmic fluorescence due to increased localization of the construct to the plasma membrane (Fig. 1A) . This translocation was more conspicuous when analyzed with TIRF microscopy, which selectively visualizes fluorescent molecules near the plasma membrane (Fig. 1, A and B) . Similar translocations were observed when the cells were exposed to the membranepermeable cAMP analog 8-Br-cAMP or the Epac-selective cAMP analog 8-pCPT-2′-OMe-cAMP-AM ("007-AM"; Fig. 1B ). Inhibition of PKA with Rp-8-CPT-cAMPS did not affect the response to IBMX (fig. S1A ). The translocation was readily reversible, and repeated increases of the cAMP concentration through pulsatile application of IBMX caused oscillatory redistribution of GFP-Epac2 to and from the plasma membrane (Fig. 1C) . To minimize the potential influence of fluorescence changes that may occur as a result of alterations in cell adhesion or cell volume, we expressed a membrane-targeted red fluorescent protein (td2-CAAX) together with GFP-Epac2 and used the GFP/td2 (tdimer2) fluorescence ratio as readout for Epac2 localization (Fig. 1C) . The ability of cAMP to trigger Epac2 translocation was verified in a-toxin-permeabilized cells, where the nucleotide induced dose-dependent plasma membrane association of GFP-Epac2 (Fig. 1, D and E). Also, 007 caused rapid and reversible membrane translocation of Epac2 in this preparation (Fig. 1F) . the cytoplasmic Ca 2+ concentration and further amplified by increases in the cAMP concentration (32, 33) . An increase in the glucose concentration from 3 to 11 mM triggered membrane translocation of GFP-Epac2 after a 2-to 4-min delay ( Fig. 2A) . The translocation pattern varied between cells. Most of the cells responded with oscillations with frequencies of <0.3 min −1 ( Fig. 2A ), but some cells showed transient plasma membrane association ( fig. S1B ), stable association ( fig. S1C ), or faster oscillations (>0.3 min
; fig. S1D ). In most cells, IBMX amplified the translocation induced by glucose, indicating that the glucose response was not saturated (fig. S1 , B and C). Similarly, augmenting the cAMP concentration by the addition of GLP-1 to glucose-stimulated b cells triggered further GFP-Epac2 translocation, often associated with pronounced oscillations ( fig. S1E ). Confocal imaging of immunostained cells showed that the cAMP-increasing stimuli also triggered translocation of endogenous Epac2 ( fig. S1F ). The glucose-induced translocation of fluorescent protein-tagged Epac2 was not limited to the clonal MIN6 b cells, but was also observed in primary mouse b cells within intact pancreatic islets (Fig. 2B) . Parallel measurements of the sub-plasma membrane cAMP concentration with a translocation biosensor (34) in MIN6 b cells showed that glucoseinduced Epac2 translocation was preceded by an increase in the cAMP concentration (Fig. 2C) . Blocking cAMP formation with 2′,5′-dideoxyadenosine (DDA) or SQ 22,536 reduced the glucose-induced Epac2 translocation (Fig. 2, D and Epac2 localization. Simultaneous TIRF microscopy recordings of the sub-plasma membrane Ca 2+ concentration and GFP-Epac2 revealed that the glucose-induced GFP-Epac2 translocation was preceded by an increase in the Ca 2+ concentration (Fig. 2F) . Removal of extracellular Ca 2+ and addition of EGTA decreased the GFP-Epac2 association with the plasma membrane (Fig. 2, E without concomitant formation of cAMP is a poor stimulator of Epac2 translocation.
We next investigated cAMP-dependent Epac2 translocation under conditions in which increases in the cytoplasmic Ca 2+ concentration were prevented by depleting Ca 2+ from the intracellular stores with the sarcoendoplasmic reticulum Ca 2+ adenosine triphosphatase (SERCA) inhibitor cyclopiazonic acid (CPA) and by maintaining the cells in Ca
2+
-deficient medium supplemented with EGTA. Treatment with a combination of IBMX and the adenylyl cyclase activator forskolin caused distinct instances of GFP-Epac2 translocation in Ca 2+ -deficient medium, but the amplitude and rate of increase were suppressed compared to control (Fig. 3,  A and B) . The reduced translocation cannot be explained by a lower intracellular cAMP concentration because 8-Br-cAMP-induced translocation of GFP-Epac2 was also suppressed in Ca (Fig. 3 , F and G). Like in intact cells, a fraction of the permeabilized cells showed dissociation of Epac2 from the membrane when exposed to a sudden increase in Ca 2+ concentration ( fig. S3B ). These data suggest that increases in the cytoplasmic Ca 2+ concentration may exert dual effects: predominantly an amplification of Epac2 translocation with a less pronounced inhibition of the Epac2 membrane interaction.
Epac2 membrane translocation requires binding to cAMP and Ras
Previous studies suggest that binding of Epac2 to the plasma membrane requires intact CNB (25) and RA (25, 26) domains. To determine their roles for the translocation of Epac2, we used mutants lacking the entire CNB region (GFP-Epac2-DCNB) or containing single amino acid substitutions in either the low-affinity cAMP-binding domain (mCherry-Epac2 G114E ), the high-affinity cAMP-binding domain (mCherry-Epac2 G422D ), or both (mCherry-Epac2 G114E/G422D ) (2), as well as in the Ras binding site (mCherryEpac2 K684E ) (26) . Although the absence of CNB domains resulted in enhanced association with the membrane (Fig. 4A) , the cAMP-binding-and Ras-binding-deficient mutants were predominantly localized in the cytoplasm even after an IBMX-induced increase in the cAMP concentration (Fig. 4 , A to F), except for the mCherry-Epac2 G114E mutant, which showed translocation similar to control (Fig. 4 , C and F). We verified the unaltered cAMP-induced membrane translocation of Epac2 G114E and the impaired translocation of the other Epac2 mutants in a-toxin-permeabilized cells (Fig. 4 , G to K). Glucose induced membrane translocation of the mCherryEpac2 G114E/G422D mutant in intact MIN6 b cells, but to a substantially reduced extent compared to wild-type control (Fig. 4L) . Similarly, the glucose-induced membrane translocation of the Ras-binding-deficient mCherry-Epac2 K684E mutant in intact cells was suppressed compared to wild type and did not oscillate (Fig. 4M) . Consistent with the requirement for Ras binding, overexpression of a dominant-negative Ras mutant (Ras S17N ) suppressed the glucoseinduced plasma membrane translocation of wild-type GFP-Epac2 (Fig. 4N ). 
Ca

2+ -mediated Ras activation triggers translocation of Epac2 to the plasma membrane
To further investigate the role of Ras in Epac2 translocation, we monitored active (GTP-loaded) Ras using TIRF microscopy and a biosensor consisting of the Ras-binding domain from Raf1 fused to cyan fluorescent protein (CFP-Raf1 RBD ) (35) . An increase in the glucose concentration induced translocation of CFP-Raf1 RBD to the plasma membrane without changing the td2-CAAX reference signal, indicating activation of Ras in the plasma membrane compartment (Fig. 5A) . Simultaneous measurements revealed that the oscillations of Epac2 translocation induced by glucose or a combination of glucose and GLP-1 were paralleled by oscillations of CFP-Raf1 RBD without a significant time lag (Fig. 5, B and C) . These effects on Ras activity . n = 32 to 33; **P < 0.01 for difference from control (Student's paired t test). are probably driven by changes of the sub-plasma membrane Ca 2+ concentration. Accordingly, increases in the Ca 2+ concentration generated by repeated K + depolarizations in MIN6 b cells exposed to 007-AM consistently induced synchronized membrane recruitment of CFP-Raf1 RBD and mCherry-Epac2 that depended on the presence of Ca 2+ in the extracellular medium (Fig. 5, D  and E) . Moreover, after treatment with 007-AM and the Ca 2+ ionophore ionomycin, both mCherry-Epac2 and CFP-Raf1 RBD translocated to the plasma membrane in response to increasing concentrations of Ca 2+ (Fig. 5, F and G) . (36) . An increase of the glucose concentration induced oscillatory translocation of the GFP-RalGDS RBD in both MIN6 and primary mouse b cells, indicating periodic activation of Rap GTPases at the plasma membrane (Fig. 6, A and B) . Activation of Epac with 007-AM or a combination of forskolin and IBMX induced stable translocation of the Rap reporter, although with smaller magnitude compared to glucose (Fig. 6, C and D) . Subsequent depolarization with K + , which caused translocation of Epac2 to the membrane (Fig. 5 , D and E), induced further GFP-RalGDS RBD translocation, indicating that Rap activity is indeed controlled by the subcellular localization of Epac2 (Fig. 6, C and E) . The results from the optical assay were confirmed in a traditional Rap-GTP pull-down assay (Fig. 6F) . Consistent with the involvement of Ras in Epac2 activation, expression of the dominant-negative Ras S17N mutant reduced glucose-induced Rap activity as determined with GFP-RalGDS RBD (Fig. 6G) . To evaluate the involvement of Rap in insulin secretion, we monitored insulin secretion kinetics from individual MIN6 b cells using an assay based on detection of phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ) after autocrine activation of insulin receptors (32, 37) . Control MIN6 b cells expressing CFP and a yellow fluorescent protein (YFP)-tagged PIP 3 -binding PH domain from Akt responded to glucose stimulation or K + depolarization with translocation of the biosensor to the plasma membrane, which reflects insulin secretion. The magnitude of this translocation was significantly reduced in cells expressing a CFPtagged dominant-negative mutant of Rap1 (Rap1B S17N ) (Fig. 6 , H to J). . n = 20 cells at each concentration.
DISCUSSION
Spatial compartmentalization of signaling is an important mechanism for the specific regulation of distinct cellular functions. The present study demonstrates that the subcellular localization of Epac2 is dynamically controlled by cAMP as well as by Ca 2+ -mediated Ras activity. Epac2 undergoes glucose-and hormone-induced oscillatory translocation between the cytoplasm and the plasma membrane in insulin-secreting b cells, and this translocation is associated with activation of Rap in the plasma membrane compartment (Fig. 7) . In addition, both the high-affinity CNB domain and the RA domain are required for the dynamic redistribution of the protein.
The intracellular concentration of cAMP is the most important determinant of Epac2 translocation. The effects of agents increasing the cAMP concentration were mimicked by an Epac-selective agonist and were resistant to PKA inhibition, indicating that the translocation is directly driven by the activation of Epac and not by other cAMP-regulated processes. Half-maximal translocation was observed at 28 mM cAMP in permeabilized cells, which is similar to the 46 mM reported for the activation of Epac protein in vitro (14) . Studies of the Epac2 structure indicate that cAMP activates the protein by releasing autoinhibition of catalytic activity exerted by the regulatory region (15, 16) . However, the mechanism by which Epac2 localizes to the plasma membrane is unclear. Various observations indicate that the membrane association of Epac2 relies on the interaction between its RA domain and Ras (25, 26) , but consensus is lacking regarding the involvement of cAMP in this process. Whereas overexpression of an active Ras mutant was sufficient for Epac2 membrane localization in one study (26) , other investigators failed to observe membrane binding in the absence of cAMP (25) . It has been proposed that the N-terminal, low-affinity CNB domain is crucial for membrane association by a mechanism that does not depend on its cAMP-binding capacity (19) . The present data indicate that Epac2 resembles Epac1 in its dynamic translocation in response to cAMP signals. In addition to cAMP binding, the translocation required a functional RA domain. The deletion mutant lacking the CNB domains was localized to the membrane, indicating that the N-terminal region of the protein is not required for membrane interaction. On the basis of the observation that Epac2 with mutations that prevent either cAMP binding or interaction with Ras showed cytoplasmic distribution with little tendency to translocate, we conclude both that cAMP-induced translocation involves interaction with Ras and that Epac2 interaction with endogenous Ras protein cannot occur in the absence of cAMP. Because Epac2 does not activate Ras (30, 38) , cAMP promotes the interaction between Epac2 and Ras that is active under basal conditions. In addition to the control by cAMP, Epac2 translocation was regulated in a complex manner by Ca
2+
. The ability of cAMP to induce Epac2 translocation was suppressed in Ca 2+ -deficient media. Although the rate of cAMP formation was lower under these conditions, inhibition of Epac2 translocation could not be explained by a reduced sub-plasma membrane concentration of cAMP . The cAMP-induced translocation of Epac2 was similarly suppressed when Ca 2+ was omitted from the intracellular-like buffer in permeabilized MIN6 cells. Increases in the cytoplasmic Ca 2+ concentration typically promoted Epac2 translocation, but in some cells, the ion instead seemed to counteract the Epac2-membrane interaction. Epac2 does not have a Ca 2+ binding domain, and the ion probably affects translocation by indirect mechanisms. Because Epac2 membrane association depended on Ras, whose activity is regulated by Ca 2+ -sensitive GEFs and GTPase-activating proteins (39-41), we propose that Ca 2+ controls Epac2 localization by changes in Ras activity. The observation that Ca 2+ did not affect Epac2 localization in permeabilized cells unless GTP was present in the intracellular medium supports the involvement of a G protein (heterotrimeric guanine nucleotide-binding protein). Moreover, using a Raf kinase-based activity reporter for Ras (36), we found that glucose-and depolarizationinduced Ca 2+ increases lead to activation of Ras at the plasma membrane with kinetics similar to the translocation of Epac2. It can therefore be concluded that at least the stimulatory effect of Ca 2+ on Epac2 translocation is mediated by Ras. It is unclear why Ca 2+ sometimes promoted dissociation of Epac2 from the membrane. This effect probably involves mechanisms other than modulation of Ras because Ras activity was invariably increased by K + depolarization. Glucose triggers pulsatile insulin secretion by generating coordinated oscillations of the sub-plasma membrane concentrations of Ca 2+ and cAMP in b cells (32) . These oscillations can explain the periodic Epac2 translocation observed in glucose-and GLP-1-stimulated cells. Epac2 is important for mediating the PKA-independent stimulatory actions of cAMP on insulin secretion (2, 42) . The mechanisms involve alterations of the membrane potential, Ca 2+ signaling, secretory granule priming, and exocytosis through activation of Rap1 (6) and its effectors, including phospholipase C-e (43-45), as well as through interactions with the SUR1 subunit of the K ATP channel (42) and proteins involved in the exocytosis machinery, such as Rim2, Piccolo (46) , and SNAP25 (47) . Because these are membraneassociated proteins, it seems appropriate that Epac2 translocates to the plasma membrane upon activation. Ras and Rap are closely related GTPases. Whereas Rap1 has been implicated in cell adhesion, junction formation, and exocytosis (6, 48) , Ras promotes cell proliferation and survival (48-50) and has not been previously implicated in the regulation of insulin secretion. The present findings indicate that activation of Ras in glucose-and hormonestimulated b cells is involved in mediating the effect of cAMP on insulin secretion by recruiting Epac2 to the plasma membrane. Epac2 subsequently activates Rap1 and other potential effectors at sites of exocytosis.
Protein translocation is an efficient means to achieve spatial control of signaling processes (51) , and oscillations in signaling systems, in particular of Ca 2+ , contribute to the efficiency and specificity in the regulation of downstream events (52) . cAMP oscillations have previously been suggested to contribute to specificity by spatially restricting PKA activity (34) , and cAMP oscillations are translated into oscillations of PKA activity with the oscillatory frequency positively correlating with nuclear PKA activity and CREB (cAMP response element-binding protein) phosphorylation (53) . We now demonstrate that cAMP oscillations can be decoded also by Epac2. Our present findings show that Epac2 signaling is under dynamic spatiotemporal control of both cAMP and Ca
. Coordinated oscillations of the two messengers provide a distinct signal for precise temporal regulation of the plasma membrane pool of Epac2 effectors.
MATERIALS AND METHODS
Materials
Reagents of analytical grade and deionized water were used. IBMX, EGTA, forskolin, DDA, 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (also known as SQ 22,536), and ionomycin were from Sigma. The Epac agonist 8-pCPT-2′-O-Me-cAMP (007) and its acetoxymethyl ester derivative 007-AM as well as the protein kinase A inhibitor Rp-8-CPT-cAMPS were from Biolog Life Science Institute. The acetoxymethyl ester of the Ca 2+ indicators Fura Red and Fluo-4, Dulbecco's modified Eagle's medium, Opti-MEM, and Lipofectamine 2000 were obtained from Invitrogen. A plasmid encoding mouse Epac2 fused to GFP (GFP-Epac2) was obtained from D. Altschuler (University of Pennsylvania, Philadelphia, PA). mCherryEpac2 was generated by polymerase chain reaction amplification of mCherry with Age I and BsrG I restriction sites. Point mutations were generated by site-directed mutagenesis (QuikChange II XL Site-Directed Mutagenesis Kit, Agilent Technologies) according to the manufacturer's instructions. Epac2 lacking both CNB domains and the intervening sequence (GFPEpac2DCNB), and Epac2 lacking the RA domain (GFP-Epac2DRA) were gifts from L. Quilliam (Indiana University School of Medicine, Indianapolis, IN). The red fluorescent protein td2 was provided by R. Y. Tsien (University of California, San Diego, CA), and a version anchored to the plasma membrane (td2-CAAX) was used as an independent reference signal in ratiometric recordings. CFP-Raf1 RBD , which was used to detect the localization of Ras-GTP, was provided by M. Fivaz (Duke Graduate Medical School Singapore, Singapore), and GFP-RalGDS RBD for localization of GTP-bound Rap as well as the pGST-RalGDS-RBD plasmid for expres- sion of GST-RalGDS RBD in bacteria were gifts from H. Rehmann and J. L. Bos (University Medical Centre Utrecht, Netherlands). Adenoviral vectors expressing mCherry-Epac2, GFP-RalGDS RBD , and Ras S17N were generated by Vector BioLabs.
Cell culture and transfection
MIN6 b cells (54) of passages 17 to 30 were maintained in Dulbecco's modified Eagle's medium containing glucose (4.5 g/liter) and supplemented with 15% fetal calf serum, 2 mM L-glutamine, 50 mM b-mercaptoethanol, penicillin (100 U/ml), and streptomycin (100 mg/ml), at 37°C in a 5% CO 2 humidified atmosphere. For transfection,~2 × 10 5 cells were suspended in 100 ml of Opti-MEM medium containing 0.5 to 1 mg of Lipofectamine 2000 (Invitrogen) and 0.15 to 0.4 mg of plasmid DNA and plated on 25-mm poly-L-lysine-coated coverslips. Where indicated, the plasmid DNA transfection was followed by infection of the cells with 10-30 plaqueforming units per cell of adenovirus encoding Ras S17N . After 3 to 5 hours, when the cells were firmly attached, the transfection was terminated by the addition of 3 ml of complete cell culture medium, in which cells were maintained for an additional 18 to 36 hours.
Pancreatic islets were isolated with collagenase from the pancreases of 5-to 7-month-old female C57Bl/6J mice. The Uppsala ethical committee approved all animal experimental procedures. The islets were transferred to RPMI 1640 culture medium containing 5.5 mM glucose and supplemented with 10% fetal calf serum, penicillin (100 U/ml), and streptomycin (100 mg/ml) for culture for 1 to 2 days at 37°C in a 5% CO 2 humidified air atmosphere. The islets were infected with mCherry-Epac2-or GFPRalGDS RBD -expressing adenoviruses at a concentration of 10 7 plaqueforming units per islet in 250 to 500 ml for 2 hours, followed either by washing with normal RPMI 1640 medium and further culture for 16 to 20 hours before use (GFP-RalGDS RBD ) or by addition of 2.5 ml of medium (without washing) and overnight culture (mCherry-Epac2).
Buffers and permeabilization
Before imaging experiments, the cells or islets were transferred to a buffer containing 125 mM NaCl, 4.8 mM KCl, 1.3 mM CaCl 2 , 1.2 mM MgCl 2 , 3 mM glucose, and 25 mM Hepes (pH adjusted to 7.40 with NaOH), and incubated for 40 to 60 min at 37°C. Continued experiments were made with the coverslips mounted in an open 50-ml chamber with buffer superfused at a rate of 0.3 ml/min. If not otherwise stated, test substances were used at the following concentrations: 11 or 20 mM glucose, 10 nM GLP-1, 10 mM forskolin, 100 mM IBMX (50 mM when combined with forskolin), 30 mM K + (total concentration; additions made with equimolar reduction of Na + to maintain osmolarity), 100 mM CPA, 50 to 100 mM DDA, 2 mM EGTA, 0.25 mM GTP, 1 mM ionomycin, 400 mM SQ 22,536, 100 mM Rp-8-CPT-cAMPS, 2.5 mM 8-Br-cAMP, 100 mM cAMP, 1 mM 007-AM, and 100 mM 007 sodium salt. Where indicated, the MIN6 cells were permeabilized with a-toxin from Staphylococcus aureus (PhPlate). The cells were then superfused with an intracellular-like medium containing 140 mM KCl, 6 mM NaCl, 1 mM MgCl 2 , 0.465 mM CaCl 2 , 2 mM EGTA, 2 mM N-(2-hydroxyethyl)ethylenediamine-N,N′,N′-triacetic acid (HEDTA), 1 mM Mg-ATP, 0.25 mM Na-GTP, 100 mM IBMX, and 10 mM Hepes (pH adjusted to 7.00 with KOH). For permeabilization with a-toxin, superfusion was temporarily interrupted, and 5 ml of a-toxin (0.46 mg/ml) was added directly into the 50-ml superfusion chamber. After 2 to 5 min, cells were washed and 0.1 mM to 1 mM cAMP were added to the medium, whereas the concentrations of Mg 2+ and Ca 2+ were maintained at 1 mM and 0.1 mM, respectively. In some experiments, the free Ca 2+ concentration was increased to 0.5-10 mM by addition of appropriate amounts of CaCl 2 . Calculations of the Mg 2+ and Ca 2+ concentrations were done with MAXCHELATOR software (http://maxchelator.stanford.edu).
Measurements of the cytoplasmic Ca
2+ concentration beneath the plasma membrane
The cells were loaded with the Ca 2+ indicators Fluo-4 or Fura Red by 30 to 60 min of incubation at 37°C in experimental buffer supplemented with 5 mM of respective acetoxymethyl ester. After rinsing the cells in indicatorfree medium, measurements of the sub-plasma membrane Ca 2+ concentration were performed with a TIRF microscope setup described below.
Measurements of cAMP concentration beneath the plasma membrane
The sub-plasma membrane concentration of cAMP was measured with a fluorescent translocation biosensor as previously described (34) . The biosensor consists of a membrane-anchored and truncated form of the PKA regulatory RIIb subunit and an YFP-labeled PKA catalytic Ca subunit (Ca-YFP). Upon rise of the cAMP concentration beneath the plasma membrane, Ca-YFP dissociates from the regulatory subunit, and this translocation is detected with TIRF microscopy as loss of YFP fluorescence. In some experiments, a CFP-tagged RIIb subunit was used and the cAMP concentration was instead recorded as changes of the CFP/YFP ratio.
Single-cell recordings of insulin secretion
The dynamics of insulin secretion from individual cells was determined by monitoring the phosphoinositide 3-kinase-mediated formation of PIP 3 in the plasma membrane, which follows autocrine activation of insulin receptors. The pleckstrin homology domain from Akt fused to YFP (PH Akt -YFP) was used as a translocation biosensor for PIP 3 as previously described (32) .
Pull-down assay for Rap activity
The amount of GTP-Rap1 was determined essentially as previously reported (38) . In brief, MIN6 b cells were seeded in 100-mm dishes (10 7 cells per dish) and cultured for 2 days. The cells were subsequently washed with cold phosphate-buffered saline on ice and lysed in cell lysis buffer [1% NP-40; 10% glycerol, 50 mM tris-HCl (pH 7.4), 200 mM NaCl, 2.5 mM MgCl 2 , 1 mM phenylmethylsulfonyl fluoride, 2 mM Na 3 VO 4 , and Halt protease inhibitor cocktail (Thermo Scientific)]. Lysates were clarified and incubated with an excess of GST-RalGDS-RBD immobilized on glutathione beads (Sigma) to pull out active Rap1. The amount of active Rap1 and total Rap1 was determined by Western blotting with a monoclonal anti-Rap1 antibody (BD Biosciences) that recognizes both Rap1A and Rap1B. A goat anti-mouse secondary antibody conjugated to horseradish peroxidase (GE Healthcare) was applied, and the chemiluminescence reaction was carried out with Immobilon Western Chemiluminescent HRP Substrate (Millipore). Quantification of Rap1 protein was performed by densitometric analysis of Western blots with ImageJ (National Institutes of Health).
Immunofluorescence
Cells grown on chamber slides were fixed with 4% paraformaldehyde for 15 min at room temperature followed by 40 min of washing and permeabilization in 0.1% Triton X-100. The cells were then incubated with an Epac2 mouse monoclonal antibody (1:50 dilution, Sc-28326; Santa Cruz Biotechnology) at 4°C for 19 hours, followed by overnight incubation with a goat anti-mouse Alexa Fluor 568 (AF-568)-conjugated secondary antibody (1:300; Invitrogen). The chamber slides were finally mounted in ProLong Gold mounting medium (Invitrogen), and the samples were imaged with a confocal microscope (see below).
Fluorescence microscopy
The subcellular distribution of fluorescence-tagged proteins was assessed with a spinning disc confocal unit (Yokogawa CSU-10) attached to a Nikon TE2000-U microscope. Light of 488 nm for excitation of GFP and of 561 nm for excitation of AF-568 and mCherry were provided by a multiline argon laser (ALC 60X, Creative Laser Production) and a diode-pumped solid-state laser (Jive, Cobolt AB), respectively. An acousto-optic tunable filter (AA Optoelectronics) was used for selection of excitation wavelength and to block the beam between image captures. Fluorescence from the cells was collected with a 60× 1.4 NA (numerical aperture) oil immersion objective (Nikon) and detected through a 530/50 nm half-bandwidth interference filter (GFP) or a 625LP filter (AF-568, mCherry) with a back-illuminated EMCCD (electronmultiplying charge-coupled device) camera (DU-888, Andor Technology, Belfast) controlled by MetaFluor software (Molecular Devices Corp.).
Fluorescence in the sub-plasma membrane compartment was recorded with a TIRF microscopy setup based on an E600FN upright microscope (Nikon) contained in an acrylic glass box thermostated at 37°C by an air stream incubator. A helium-cadmium laser (Kimmon) provided 442-nm light for excitation of CFP, and an argon laser (ALC 60X) provided 488-and 514-nm light for excitation of GFP and YFP, respectively. Another Jive diode-pumped solid-state laser (Cobolt AB) provided 561-nm light for td2 and mCherry excitation. The laser beams were merged with dichroic mirrors (Chroma Technology), homogenized, and expanded by a rotating Light Shaping Diffuser (Physical Optics Corp.) before being refocused through a modified quartz dove prism (Axicon) with 70°angle to achieve total internal reflection. Laser lines were selected with interference filters (Semrock) in a motorized filter wheel equipped with a shutter (Sutter Instruments) blocking the beam between image captures. The coverslips with attached cells were used as exchangeable bottoms of an open 200-ml superfusion chamber. The chamber was mounted on the custom-built stage of the microscope such that the coverslip was maintained in contact with the dove prism by a thin layer of immersion oil. Fluorescence from the cells was collected through a 40× 0.8 NA water immersion objective (Nikon) and detected at 530/50 nm for GFP, 485/25 nm for CFP, and 542/27 nm for YFP (Semrock interference filters) or 625LP for td2/mCherry/Fura Red (Melles Griot glass filter) with a CCD camera (ORCA-AG) under MetaFluor software control. Images were acquired every 1 to 5 s with exposure times in the 100-to 400-ms range. Some experiments, such as those involving intact pancreatic islets or a-toxin-permeabilized cells, were performed at an alternative TIRF imaging setup based on an inverted Eclipse Ti microscope (Nikon) equipped with a 60× 1.45 NA objective as previously described (55) .
Image analysis and statistics
Images were analyzed with MetaFluor. Changes of fluorescence intensity over time were recorded from manually defined regions of interest corresponding to individual cells. The data were normalized by expressing the fluorescence or fluorescence ratio relative to the prestimulatory intensity or ratio after background subtraction. All experiments were repeated a minimum of three times, and the data are expressed as means ± SE. A two-tailed Student's t test was used to assess statistical differences, and P values <0.05 were considered statistically significant.
SUPPLEMENTARY MATERIALS
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